[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"options:asyncdata:q6hozTqCnNUZdra_I9kcNQ9xv32WkFSRN6Xz2RW_BY4":3},{"blogPost":4,"otherBlogs":85},{"id":5,"date":6,"date_gmt":6,"guid":7,"modified":9,"modified_gmt":9,"slug":10,"status":11,"type":12,"link":13,"title":14,"content":16,"excerpt":19,"author":21,"featured_media":22,"comment_status":23,"ping_status":23,"sticky":18,"template":24,"format":25,"meta":26,"categories":28,"tags":30,"class_list":31,"featured_media_src_url":40,"_links":41},235,"2025-05-15T13:57:07",{"rendered":8},"https:\u002F\u002Fwp.ncikenya.go.ke\u002F?p=235","2025-05-15T13:57:34","nci-k-pursues-research-institution-accreditation","publish","post","https:\u002F\u002Fwp.ncikenya.go.ke\u002F2025\u002F05\u002F15\u002Fnci-k-pursues-research-institution-accreditation\u002F",{"rendered":15},"NCI-K Pursues Research Institution Accreditation",{"rendered":17,"protected":18},"\n\u003Ch2 class=\"wp-block-heading\">NACOSTI Visits NCI-K\u003C\u002Fh2>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Today, the National Cancer Institute of Kenya hosted a delegation from the National Commission for Science, Technology and Innovation (NACOSTI), a state corporation mandated to regulate and assure quality in science, technology, and innovation.\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-image is-resized\">\u003Cimg loading=\"lazy\" decoding=\"async\" width=\"2560\" height=\"1814\" src=\"https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-content\u002Fuploads\u002F2025\u002F05\u002FDSC_4639-scaled.jpg\" alt=\"\" class=\"wp-image-236\" style=\"width:589px;height:auto\" srcset=\"https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-content\u002Fuploads\u002F2025\u002F05\u002FDSC_4639-scaled.jpg 2560w, https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-content\u002Fuploads\u002F2025\u002F05\u002FDSC_4639-300x213.jpg 300w, https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-content\u002Fuploads\u002F2025\u002F05\u002FDSC_4639-1024x726.jpg 1024w, https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-content\u002Fuploads\u002F2025\u002F05\u002FDSC_4639-768x544.jpg 768w, https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-content\u002Fuploads\u002F2025\u002F05\u002FDSC_4639-1536x1089.jpg 1536w, https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-content\u002Fuploads\u002F2025\u002F05\u002FDSC_4639-2048x1451.jpg 2048w\" sizes=\"auto, (max-width: 2560px) 100vw, 2560px\" \u002F>\u003C\u002Ffigure>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">The primary purpose of the visit was to assess NCI-K&#8217;s capacity to be registered as a research institution. This is one of NCI-K&#8217;s commitments to not only provide top-tier cancer care but also contribute to the advancement of cancer research in Kenya.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Dr. Elias Melly, CEO of NCI-K, warmly welcomed the NACOSTI team, emphasizing the importance of this assessment for the institute&#8217;s future endeavors.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">The NACOSTI team was led by Prof. Vassey Mwaja, Ph.D., Vice Chairperson of the African Scientific Research and Innovation, and Prof. Mabel Imbuga, former Vice Chancellor of Jomo Kenyatta University of Agriculture and Technology (JKUAT), Situma Stephen, Christine Anakoeng, among other distinguished members.\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-image\">\u003Cimg loading=\"lazy\" decoding=\"async\" width=\"2560\" height=\"1707\" src=\"https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-content\u002Fuploads\u002F2025\u002F05\u002FDSC_4632-scaled.jpg\" alt=\"\" class=\"wp-image-237\" srcset=\"https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-content\u002Fuploads\u002F2025\u002F05\u002FDSC_4632-scaled.jpg 2560w, https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-content\u002Fuploads\u002F2025\u002F05\u002FDSC_4632-300x200.jpg 300w, https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-content\u002Fuploads\u002F2025\u002F05\u002FDSC_4632-1024x683.jpg 1024w, https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-content\u002Fuploads\u002F2025\u002F05\u002FDSC_4632-768x512.jpg 768w, https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-content\u002Fuploads\u002F2025\u002F05\u002FDSC_4632-1536x1024.jpg 1536w, https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-content\u002Fuploads\u002F2025\u002F05\u002FDSC_4632-2048x1365.jpg 2048w\" sizes=\"auto, (max-width: 2560px) 100vw, 2560px\" \u002F>\u003C\u002Ffigure>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">This visit is an important step in NCI-K&#8217;s journey to becoming a recognized research institution, a journey towards full implementation of the Cancer Prevention and Control Act, 2012, paving the way for greater contributions to cancer research and improved patient outcomes.\u003C\u002Fp>\n",false,{"rendered":20,"protected":18},"\u003Cp>NACOSTI Visits NCI-K Today, the National Cancer Institute of Kenya hosted a delegation from the National Commission for Science, Technology and Innovation (NACOSTI), a state corporation mandated to regulate and assure quality in science, technology, and innovation. The primary purpose of the visit was to assess NCI-K&#8217;s capacity to be registered as a research institution. [&hellip;]\u003C\u002Fp>\n",1,238,"open","","standard",{"pagelayer_contact_templates":27,"_pagelayer_content":24,"footnotes":24},[],[29,21],4,[],[32,12,33,34,35,36,37,38,39],"post-235","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news-updates","category-uncategorized","https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-content\u002Fuploads\u002F2025\u002F05\u002FDSC_4676-1024x468.jpg",{"self":42,"collection":48,"about":51,"author":54,"replies":58,"version-history":61,"predecessor-version":64,"wp:featuredmedia":68,"wp:attachment":71,"wp:term":74,"curies":81},[43],{"href":44,"targetHints":45},"https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-json\u002Fwp\u002Fv2\u002Fposts\u002F235",{"allow":46},[47],"GET",[49],{"href":50},"https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-json\u002Fwp\u002Fv2\u002Fposts",[52],{"href":53},"https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-json\u002Fwp\u002Fv2\u002Ftypes\u002Fpost",[55],{"embeddable":56,"href":57},true,"https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-json\u002Fwp\u002Fv2\u002Fusers\u002F1",[59],{"embeddable":56,"href":60},"https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-json\u002Fwp\u002Fv2\u002Fcomments?post=235",[62],{"count":21,"href":63},"https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-json\u002Fwp\u002Fv2\u002Fposts\u002F235\u002Frevisions",[65],{"id":66,"href":67},239,"https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-json\u002Fwp\u002Fv2\u002Fposts\u002F235\u002Frevisions\u002F239",[69],{"embeddable":56,"href":70},"https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-json\u002Fwp\u002Fv2\u002Fmedia\u002F238",[72],{"href":73},"https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-json\u002Fwp\u002Fv2\u002Fmedia?parent=235",[75,78],{"taxonomy":76,"embeddable":56,"href":77},"category","https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-json\u002Fwp\u002Fv2\u002Fcategories?post=235",{"taxonomy":79,"embeddable":56,"href":80},"post_tag","https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-json\u002Fwp\u002Fv2\u002Ftags?post=235",[82],{"name":83,"href":84,"templated":56},"wp","https:\u002F\u002Fapi.w.org\u002F{rel}",[86,144,196],{"id":87,"date":88,"date_gmt":88,"guid":89,"modified":88,"modified_gmt":88,"slug":91,"status":11,"type":12,"link":92,"title":93,"content":95,"excerpt":97,"author":21,"featured_media":99,"comment_status":23,"ping_status":23,"sticky":18,"template":24,"format":25,"meta":100,"categories":102,"tags":104,"class_list":105,"featured_media_src_url":108,"_links":109},790,"2026-11-19T09:50:19",{"rendered":90},"https:\u002F\u002Fwp.ncikenya.go.ke\u002F?p=790","turning-cancer-data-into-action-nci-k-champions-mandatory-cancer-reporting-at-the-9th-kenya-international-cancer-conference","https:\u002F\u002Fwp.ncikenya.go.ke\u002F2026\u002F11\u002F19\u002Fturning-cancer-data-into-action-nci-k-champions-mandatory-cancer-reporting-at-the-9th-kenya-international-cancer-conference\u002F",{"rendered":94},"Turning Cancer Data into Action: NCI-K Champions Mandatory Cancer Reporting at the 9th Kenya International Cancer Conference.",{"rendered":96,"protected":18},"\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>MOMBASA, KENYA — November 19, 2026\u003C\u002Fstrong> — The \u003Ca href=\"https:\u002F\u002Fwww.linkedin.com\u002Fcompany\u002Fnational-cancer-institute-of-kenya\u002F\">NATIONAL CANCER INSTITUTE OF KENYA\u003C\u002Fa> (NCI-K) has called upon all public and private healthcare facilities across the country to uphold their statutory duty of mandatory cancer reporting, emphasizing that verified, real-world data is the cornerstone of effective cancer control and patient survival.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Delivering a keynote presentation on the opening day of the \u003Cstrong>9th Kenya International Cancer Conference (KICC 2026)\u003C\u002Fstrong>—hosted by the \u003Ca href=\"https:\u002F\u002Fwww.linkedin.com\u002Fcompany\u002Fkenya-society-of-haematology-oncology\u002F\">Kenya Society of Haematology &amp; Oncology (KESHO)\u003C\u002Fa> in Mombasa- Mrs. \u003Ca href=\"https:\u002F\u002Fwww.linkedin.com\u002Fin\u002Fgladys-chesumbai-ba8302a4\u002F\">Gladys Chesumbai\u003C\u002Fa> , Head of the National Cancer Registry at NCI-K, highlighted the urgent need to bridge the gap between clinical diagnosis and national policy.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Speaking in alignment with the conference theme, \u003Cem>&#8220;Equity, Excellence, and Sustainable Impact in Cancer Care,&#8221;\u003C\u002Fem> Mrs. Chesumbai outlined how comprehensive cancer surveillance powers Kenya’s \u003Cstrong>National Cancer Control Strategy (2023–2027)\u003C\u002Fstrong>.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>Cancer Control Begins with Knowing the Burden\u003C\u002Fstrong>\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Guided by the strategic thesis that \u003Cem>&#8220;a country cannot plan an effective response to a burden it cannot see clearly,&#8221;\u003C\u002Fem> NCI-K’s National Cancer Registry operates on a three-pillar framework:\u003C\u002Fp>\n\n\n\n\u003Cul class=\"wp-block-list\">\n\u003Cli>\u003Cstrong>SEE:\u003C\u002Fstrong> Identifying exact cancer types by geographic location and population demographics.\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>UNDERSTAND:\u003C\u002Fstrong> Uncovering disease patterns, service delivery gaps, and healthcare inequities across counties.\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>ACT:\u003C\u002Fstrong> Aligning national health policy, clinical services, and targeted investments—such as the Social Health Authority (SHA) Enhanced Cancer Benefits Package—to meet actual population needs.\u003C\u002Fli>\n\u003C\u002Ful>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>Kenya’s Cancer Landscape: Insights from Registry &amp; GLOBOCAN Data\u003C\u002Fstrong>\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">During her presentation, Mrs. Chesumbai shared critical epidemiological insights highlighting where Kenya’s cancer burden is most concentrated:\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-image\">\u003Cimg decoding=\"async\" src=\"https:\u002F\u002Fmedia.licdn.com\u002Fdms\u002Fimage\u002Fv2\u002FD4D12AQH5FhvVmP9a_Q\u002Farticle-inline_image-shrink_1000_1488\u002FB4DaHzEBomJcAM-\u002F0\u002F1795079281637?e=1796860800&amp;v=beta&amp;t=1dFpEtmUo5zb2PiHQAUgoj2u1t7IxQUsc0a_rcpvOOU\" alt=\"Article content\"\u002F>\u003Cfigcaption class=\"wp-element-caption\">Top Five Cancer Data Presentation\u003C\u002Ffigcaption>\u003C\u002Ffigure>\n\n\n\n\u003Cul class=\"wp-block-list\">\n\u003Cli>\u003Cstrong>Top Five Cancers Drive Over Half of All Cases:\u003C\u002Fstrong> According to GLOBOCAN 2024 incidence and mortality data presented at the forum, five cancers account for \u003Cstrong>52.3% of all cancer cases\u003C\u002Fstrong> in Kenya: \u003Cstrong>Breast Cancer:\u003C\u002Fstrong> 16.2% (6,822 new cases; 2,882 annual deaths) \u003Cstrong>Cervical Cancer:\u003C\u002Fstrong> 12.0% (4,294 new cases; 2,606 annual deaths) \u003Cstrong>Prostate Cancer:\u003C\u002Fstrong> 10.0% (3,661 new cases; 2,136 annual deaths) \u003Cstrong>Oesophageal Cancer:\u003C\u002Fstrong> 7.1% (2,532 new cases; 2,353 annual deaths) \u003Cstrong>Colorectal Cancer:\u003C\u002Fstrong> 7.0% (2,525 new cases; 1,411 annual deaths)\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>County-Level Surveillance:\u003C\u002Fstrong> Data from the 2024 national registry tracking illustrates how mapping cases by county of residence—led by Nairobi (1,428 cases), Kiambu (947), Nakuru (854), Nyeri (844), and Meru (841)—enables health authorities to identify high-burden regions and tailor county-level interventions.\u003C\u002Fli>\n\u003C\u002Ful>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>A Statutory National Responsibility\u003C\u002Fstrong>\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Mrs. Chesumbai reminded clinicians, pathologists, laboratory specialists, and hospital administrators that cancer notification is not optional. Under the \u003Cstrong>Cancer Prevention and Control Act (2012), Cap. 246B\u003C\u002Fstrong>, cancer reporting is \u003Cstrong>mandatory across all health facilities\u003C\u002Fstrong> in Kenya.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">To achieve a truly comprehensive National Cancer Registry, NCI-K is enforcing four key operational standards:\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-image\">\u003Cimg decoding=\"async\" src=\"https:\u002F\u002Fmedia.licdn.com\u002Fdms\u002Fimage\u002Fv2\u002FD4D12AQFn-iaYfvD7WQ\u002Farticle-inline_image-shrink_1000_1488\u002FB4DaHzEi69GQAM-\u002F0\u002F1795079418024?e=1796860800&amp;v=beta&amp;t=bJFSpBBTWVyiLCtmyzdawwnrW9mMNvbp4FUOVqvUfvs\" alt=\"Article content\"\u002F>\u003Cfigcaption class=\"wp-element-caption\">Statutory Responsibility Presentation\u003C\u002Ffigcaption>\u003C\u002Ffigure>\n\n\n\n\u003Cul class=\"wp-block-list\">\n\u003Cli>\u003Cstrong>Universal Coverage:\u003C\u002Fstrong> A binding reporting duty across both public and private health facilities.\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>Seamless Pathways:\u003C\u002Fstrong> Establishing direct digital and operational links from diagnosis to capture in the National Cancer Registry.\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>Multidisciplinary Alignment:\u003C\u002Fstrong> Ensuring coordinated reporting among attending clinicians, pathologists, and diagnostic laboratories.\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>System Accountability:\u003C\u002Fstrong> Maintaining audited quality standards for complete, accurate, and timely data submission.\u003C\u002Fli>\n\u003C\u002Ful>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>Translating Evidence into Lifesaving Impact\u003C\u002Fstrong>\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Concluding her address on \u003Cem>&#8220;From Cancer Data to Decisions That Save Lives,&#8221;\u003C\u002Fem> Mrs. Chesumbai demonstrated how verified registry evidence directly informs on-the-ground action:\u003C\u002Fp>\n\n\n\n\u003Col class=\"wp-block-list\">\n\u003Cli>\u003Cstrong>Policy &amp; Priorities:\u003C\u002Fstrong> Guiding targeted community screening and early detection outreach for high-burden cancers across counties.\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>Planning &amp; Investment:\u003C\u002Fstrong> Supporting the equitable deployment and equipping of regional cancer centers across the country.\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>Accountability &amp; Survivorship:\u003C\u002Fstrong> Tracking treatment outcomes and measurable survival gains over time to improve cancer survivors&#8217; quality of life.\u003C\u002Fli>\n\u003C\u002Fol>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">As KICC 2026 continues in Mombasa through November 21, the National Cancer Institute of Kenya remains committed to collaborating with healthcare providers, researchers, county governments, and development partners to strengthen cancer surveillance and build a healthier, cancer-free nation.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003C\u002Fp>\n",{"rendered":98,"protected":18},"\u003Cp>MOMBASA, KENYA — November 19, 2026 — The NATIONAL CANCER INSTITUTE OF KENYA (NCI-K) has called upon all public and private healthcare facilities across the country to uphold their statutory duty of mandatory cancer reporting, emphasizing that verified, real-world data is the cornerstone of effective cancer control and patient survival. Delivering a keynote presentation on [&hellip;]\u003C\u002Fp>\n",791,{"pagelayer_contact_templates":101,"_pagelayer_content":24,"footnotes":24},[],[103,29],36,[],[106,12,33,34,35,36,37,107,38],"post-790","category-cancer-summit","https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-content\u002Fuploads\u002F2026\u002F11\u002FWhatsApp-Image-2026-11-19-at-09.08.05-1024x1024.jpeg",{"self":110,"collection":115,"about":117,"author":119,"replies":121,"version-history":124,"predecessor-version":127,"wp:featuredmedia":131,"wp:attachment":134,"wp:term":137,"curies":142},[111],{"href":112,"targetHints":113},"https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-json\u002Fwp\u002Fv2\u002Fposts\u002F790",{"allow":114},[47],[116],{"href":50},[118],{"href":53},[120],{"embeddable":56,"href":57},[122],{"embeddable":56,"href":123},"https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-json\u002Fwp\u002Fv2\u002Fcomments?post=790",[125],{"count":21,"href":126},"https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-json\u002Fwp\u002Fv2\u002Fposts\u002F790\u002Frevisions",[128],{"id":129,"href":130},792,"https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-json\u002Fwp\u002Fv2\u002Fposts\u002F790\u002Frevisions\u002F792",[132],{"embeddable":56,"href":133},"https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-json\u002Fwp\u002Fv2\u002Fmedia\u002F791",[135],{"href":136},"https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-json\u002Fwp\u002Fv2\u002Fmedia?parent=790",[138,140],{"taxonomy":76,"embeddable":56,"href":139},"https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-json\u002Fwp\u002Fv2\u002Fcategories?post=790",{"taxonomy":79,"embeddable":56,"href":141},"https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-json\u002Fwp\u002Fv2\u002Ftags?post=790",[143],{"name":83,"href":84,"templated":56},{"id":145,"date":146,"date_gmt":146,"guid":147,"modified":146,"modified_gmt":146,"slug":149,"status":11,"type":12,"link":150,"title":151,"content":153,"excerpt":155,"author":21,"featured_media":156,"comment_status":23,"ping_status":23,"sticky":18,"template":24,"format":25,"meta":157,"categories":159,"tags":160,"class_list":161,"featured_media_src_url":163,"_links":164},765,"2026-11-03T11:47:53",{"rendered":148},"https:\u002F\u002Fwp.ncikenya.go.ke\u002F?p=765","nci-k-translated-service-delivery-charter-sign-language-audio-visual","https:\u002F\u002Fwp.ncikenya.go.ke\u002F2026\u002F11\u002F03\u002Fnci-k-translated-service-delivery-charter-sign-language-audio-visual\u002F",{"rendered":152},"NCI-K TRANSLATED SERVICE DELIVERY CHARTER SIGN LANGUAGE\u002FAUDIO VISUAL",{"rendered":154,"protected":18},"\n\u003Cfigure class=\"wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio\">\u003Cdiv class=\"wp-block-embed__wrapper\">\n\u003Ciframe loading=\"lazy\" title=\"National Cancer Institute of Kenya Service Deliver Charter in Kenya Sign Language\" width=\"500\" height=\"281\" src=\"https:\u002F\u002Fwww.youtube.com\u002Fembed\u002F_Em_krVSfU0?start=97&amp;feature=oembed\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share\" referrerpolicy=\"strict-origin-when-cross-origin\" allowfullscreen>\u003C\u002Fiframe>\n\u003C\u002Fdiv>\u003C\u002Ffigure>\n",{"rendered":24,"protected":18},0,{"pagelayer_contact_templates":158,"_pagelayer_content":24,"footnotes":24},[],[21],[],[162,12,33,34,35,37,39],"post-765",null,{"self":165,"collection":170,"about":172,"author":174,"replies":176,"version-history":179,"predecessor-version":182,"wp:attachment":186,"wp:term":189,"curies":194},[166],{"href":167,"targetHints":168},"https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-json\u002Fwp\u002Fv2\u002Fposts\u002F765",{"allow":169},[47],[171],{"href":50},[173],{"href":53},[175],{"embeddable":56,"href":57},[177],{"embeddable":56,"href":178},"https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-json\u002Fwp\u002Fv2\u002Fcomments?post=765",[180],{"count":21,"href":181},"https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-json\u002Fwp\u002Fv2\u002Fposts\u002F765\u002Frevisions",[183],{"id":184,"href":185},766,"https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-json\u002Fwp\u002Fv2\u002Fposts\u002F765\u002Frevisions\u002F766",[187],{"href":188},"https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-json\u002Fwp\u002Fv2\u002Fmedia?parent=765",[190,192],{"taxonomy":76,"embeddable":56,"href":191},"https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-json\u002Fwp\u002Fv2\u002Fcategories?post=765",{"taxonomy":79,"embeddable":56,"href":193},"https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-json\u002Fwp\u002Fv2\u002Ftags?post=765",[195],{"name":83,"href":84,"templated":56},{"id":197,"date":198,"date_gmt":198,"guid":199,"modified":198,"modified_gmt":198,"slug":201,"status":11,"type":12,"link":202,"title":203,"content":205,"excerpt":207,"author":21,"featured_media":209,"comment_status":23,"ping_status":23,"sticky":18,"template":24,"format":25,"meta":210,"categories":212,"tags":214,"class_list":215,"featured_media_src_url":218,"_links":219},736,"2026-10-06T18:27:09",{"rendered":200},"https:\u002F\u002Fwp.ncikenya.go.ke\u002F?p=736","nci-k-hosts-ampath-flow-cytometry-team-to-strengthen-cancer-diagnostic-services","https:\u002F\u002Fwp.ncikenya.go.ke\u002F2026\u002F10\u002F06\u002Fnci-k-hosts-ampath-flow-cytometry-team-to-strengthen-cancer-diagnostic-services\u002F",{"rendered":204},"NCI-K Hosts AMPATH Flow Cytometry Team to Strengthen Cancer Diagnostic Services.",{"rendered":206,"protected":18},"\n\u003Cp class=\"wp-block-paragraph\">The National Cancer Institute of Kenya (NCI-K) today hosted a team from the AMPATH Flow Cytometry Program (AFCP) for a meeting with the NCI-K leadership. The team was received by the Director of the Cancer Prevention and Control Directorate, Dr. Nashat Fadhloon Noor.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">The engagement focused on strengthening collaboration and advancing cancer diagnosis through specialized laboratory technologies, including flow cytometry, which plays an important role in the diagnosis and management of several cancers, particularly haematological malignancies.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Key areas discussed included:\u003C\u002Fp>\n\n\n\n\u003Cul class=\"wp-block-list\">\n\u003Cli>Recognition of flow cytometry as an essential specialized cancer diagnostic service.\u003C\u002Fli>\n\n\n\n\u003Cli>Adoption of panel-based reimbursement rather than individual antibody-based reimbursement.\u003C\u002Fli>\n\n\n\n\u003Cli>Appropriate reimbursement for immunohistochemistry (IHC) panels.\u003C\u002Fli>\n\n\n\n\u003Cli>Development of national technical and quality standards for specialized cancer diagnostics.\u003C\u002Fli>\n\n\n\n\u003Cli>Establishment of coordinated specimen-referral pathways.\u003C\u002Fli>\n\n\n\n\u003Cli>Recognition of qualified reference laboratories to support testing, training and quality assurance.\u003C\u002Fli>\n\u003C\u002Ful>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">The AMPATH delegation included Dr. Teresa Lotodo, Lead Pathologist and Chair, Pathology Department, Moi University &amp; Medical Director, Flow Cytometry Laboratory; Raphael Koima, AFCP Program Manager\u002FCoordinator; Dr. Gilbert Olbara, Lead Clinician and Head of Paediatric Oncology, MTRH; Dr. Ronald Tonui, Director, AMPATH Reference Laboratory; and Nicholas Kigen, Lead Laboratory Scientist, ARL.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">The meeting reaffirmed the importance of strategic partnerships, innovation and strengthened diagnostic capacity in improving early and accurate cancer diagnosis and ultimately advancing Kenya’s cancer response.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">NCI-K remains committed to building partnerships that strengthen cancer prevention, diagnosis, treatment and care towards a cancer-free nation.\u003C\u002Fp>\n",{"rendered":208,"protected":18},"\u003Cp>The National Cancer Institute of Kenya (NCI-K) today hosted a team from the AMPATH Flow Cytometry Program (AFCP) for a meeting with the NCI-K leadership. The team was received by the Director of the Cancer Prevention and Control Directorate, Dr. Nashat Fadhloon Noor. The engagement focused on strengthening collaboration and advancing cancer diagnosis through specialized [&hellip;]\u003C\u002Fp>\n",737,{"pagelayer_contact_templates":211,"_pagelayer_content":24,"footnotes":24},[],[29,213],43,[],[216,12,33,34,35,36,37,38,217],"post-736","category-partnerships","https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-content\u002Fuploads\u002F2026\u002F10\u002FDSC_5500.JPG-1024x683.jpeg",{"self":220,"collection":225,"about":227,"author":229,"replies":231,"version-history":234,"predecessor-version":237,"wp:featuredmedia":241,"wp:attachment":244,"wp:term":247,"curies":252},[221],{"href":222,"targetHints":223},"https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-json\u002Fwp\u002Fv2\u002Fposts\u002F736",{"allow":224},[47],[226],{"href":50},[228],{"href":53},[230],{"embeddable":56,"href":57},[232],{"embeddable":56,"href":233},"https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-json\u002Fwp\u002Fv2\u002Fcomments?post=736",[235],{"count":21,"href":236},"https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-json\u002Fwp\u002Fv2\u002Fposts\u002F736\u002Frevisions",[238],{"id":239,"href":240},738,"https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-json\u002Fwp\u002Fv2\u002Fposts\u002F736\u002Frevisions\u002F738",[242],{"embeddable":56,"href":243},"https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-json\u002Fwp\u002Fv2\u002Fmedia\u002F737",[245],{"href":246},"https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-json\u002Fwp\u002Fv2\u002Fmedia?parent=736",[248,250],{"taxonomy":76,"embeddable":56,"href":249},"https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-json\u002Fwp\u002Fv2\u002Fcategories?post=736",{"taxonomy":79,"embeddable":56,"href":251},"https:\u002F\u002Fwp.ncikenya.go.ke\u002Fwp-json\u002Fwp\u002Fv2\u002Ftags?post=736",[253],{"name":83,"href":84,"templated":56}]